Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment.
AuthorCole, Thomas O
Greenblatt, Aaron D
Belcher, Annabelle M
JournalFrontiers in Public Health
PublisherFrontiers Media S.A.
MetadataShow full item record
AbstractTelemedicine is increasingly being used to treat patients with opioid use disorder (OUD). It has particular value in rural areas of the United States impacted by the opioid crisis as these areas have a shortage of trained addiction medicine providers. Patient satisfaction significantly impacts positive clinical outcomes in OUD treatment and thus is of great clinical interest. Yet little is known regarding patient satisfaction with the increasingly important platform of telemedicine-delivered medications for opioid use disorder (tMOUD). The goal of this review is to provide a summary of the existing literature regarding patient satisfaction with tMOUD. We also submit a novel survey based on an existing framework designed to assess tMOUD satisfaction, and present pilot data (N = 14) acquired from patients engaged in rural tMOUD care. Telemedicine provides a feasible method for delivering MOUD in rural areas, and our survey provides a useful assessment to measure patient satisfaction with tMOUD. In light of the pressing need for innovative and technology-driven solutions to the opioid epidemic (especially in light of the COVID-19 pandemic), future research should focus on the development and refinement of tools to assess the important implementation goal of patient satisfaction.
Rights/TermsCopyright © 2021 Cole, Robinson, Kelley-Freeman, Gandhi, Greenblatt, Weintraub and Belcher.
medication assisted treatment
opioid use disorder
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/14703
- Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
- Authors: Nunes EV, Levin FR, Reilly MP, El-Bassel N
- Issue date: 2021 Mar
- Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
- Authors: Weintraub E, Seneviratne C, Anane J, Coble K, Magidson J, Kattakuzhy S, Greenblatt A, Welsh C, Pappas A, Ross TL, Belcher AM
- Issue date: 2021 Aug 2
- Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
- Authors: Rhee TG, Rosenheck RA
- Issue date: 2019 Nov
- Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
- Authors: Peckham AM, Ball J, Colvard MD, Dadiomov D, Hill LG, Nichols SD, Tallian K, Ventricelli DJ, Tran TH
- Issue date: 2021 Mar 18
- Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
- Authors: Molfenter T, Knudsen HK, Brown R, Jacobson N, Horst J, Van Etten M, Kim JS, Haram E, Collier E, Starr S, Toy A, Madden L
- Issue date: 2017 Nov 15